AIR2LIFE

Automatic resuscitation for ventilation in cardiopulmonary resuscitation.

AIR2LIFE develops an advanced automatic ventilation device designed to support cardiopulmonary resuscitation (CPR) in cases of sudden cardiac arrest.

The innovative solution, led by Dipneo in collaboration with Eurecat, assists both professional and non-professional first responders by automating the ventilation process during CPR, optimising patient survival rates.

Cardiac arrest is a leading cause of mortality globally, with survival rates decreasing by 10% for each minute without proper intervention. Current manual resuscitation devices require physical effort and trained personnel, limiting their effectiveness in emergency situations.

AIR2LIFE addresses these limitations by providing an autonomous, easy-to-use and portable solution that guarantees adequate ventilation and synchronisation with chest compressions.

The device integrates IoT communication, allowing real-time monitoring, remote assistance through telemedicine and augmented reality guidance for its correct use. AIR2LIFE offers a lightweight and cost-effective alternative to traditional resuscitation equipment, improving usability and safety.

The project also focuses on obtaining CE certification, conducting preclinical and clinical validation tests and developing a digital platform for professional supervision and data management.

With the potential to become a critical tool in the field of emergency healthcare, AIR2LIFE targets deployment in public spaces, healthcare facilities and emergency response systems.

Eurecat participates in AIR2LIFE through its Digital Health Unit.